IP Verse

A Novel Process For Preparation Of Indacaterol Or Its Pharmaceutically Acceptable Salts - EP3092217

The patent EP3092217 was granted to Davuluri on Jun 3, 2020. The application was originally filed on Dec 27, 2014 under application number EP14877661A. The patent is currently recorded with a legal status of "Revoked".

EP3092217

DAVULURI
Application Number
EP14877661A
Filing Date
Dec 27, 2014
Status
Revoked
Jul 19, 2024
Publication Date
Jun 3, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

PATENTANWALTSMar 1, 2021FABRY -

Patent Citations (21) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS6878721
DESCRIPTIONUS7534890
DESCRIPTIONWO0075114
DESCRIPTIONWO2004087668
DESCRIPTIONWO2005123684
DESCRIPTIONWO2008093188
DESCRIPTIONWO2013132514
DESCRIPTIONWO2014044288
DESCRIPTIONWO2014044566
DESCRIPTIONWO2014154841
INTERNATIONAL-SEARCH-REPORTWO0075114
INTERNATIONAL-SEARCH-REPORTWO2013132514
INTERNATIONAL-SEARCH-REPORTWO2014044288
INTERNATIONAL-SEARCH-REPORTWO2014154841
OPPOSITIONWO0075114
OPPOSITIONWO03042160
OPPOSITIONWO2004076422
OPPOSITIONWO2013132514
OPPOSITIONWO2014044566
OPPOSITIONWO2014154841
SEARCHWO2014044566

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- Biorganic & Medicinal Chemistry Letters, (20110301), vol. 21, no. 5, pages 1354 - 1358
OPPOSITION- "N-Methyl-2-pyrrolidone", Concise International Chemical Assessment Document 35, Geneva, (20010000), XP055790656
OPPOSITION- T. W. GREENE et al., Protective Groups in Organic Synthesis, New York, (19990000), pages 76 - 79,127-141, XP055790654
OPPOSITION- HUGHES et al., "Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules", Bioorg. Med. Chem. Lett., (20110000), vol. 21, no. 5, pages 1354 - 1358, XP055011968
OPPOSITION- MATHRE et al., "A Practical Enantioselective Synthesis of alpha,alpha-Diaryl-2- pyrrolidinemethanol . Preparation and Chemistry of the Corresponding Oxazab- orolidines", J. Org. Chem., (19910000), vol. 56, pages 751 - 762, XP002200364
SEARCH- ADAM D. HUGHES ET AL, "Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (20110301), vol. 21, no. 5, doi:10.1016/j.bmcl.2011.01.043, ISSN 0960-894X, pages 1354 - 1358, XP055011968 [A] 1 * compound 15 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents